Page 20 - Beck Bode News Today

Arcadia Investment Management Corp MI purchased a new stake in shares of Celsius Holdings, Inc. (NASDAQ:CELH – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm purchased 2,306 shares of the company’s stock, valued at approximately $240,000. Several other institutional investors have also recently made changes to their positions in CELH. Thrivent Financial […]

Gulf International Bank UK Ltd lessened its holdings in shares of Hewlett Packard Enterprise (NYSE:HPE – Get Rating) by 0.6% in the 4th quarter, HoldingsChannel reports. The firm owned 213,093 shares of the technology company’s stock after selling 1,218 shares during the quarter. Gulf International Bank UK Ltd’s holdings in Hewlett Packard Enterprise were worth […]

StockNews.com began coverage on shares of Core Laboratories (NYSE:CLB – Get Rating) in a report issued on Wednesday morning. The firm issued a hold rating on the oil and gas company’s stock. Several other brokerages have also recently issued reports on CLB. Piper Sandler upped their price objective on Core Laboratories from $18.00 to $19.00 […]

Decade Renewable Partners LP bought a new position in shares of Ameren Co. (NYSE:AEE – Get Rating) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 114,500 shares of the utilities provider’s stock, valued at approximately $10,181,000. Ameren accounts for about 3.8% of Decade Renewable Partners LP’s holdings, making the stock its 10th largest […]

Crewe Advisors LLC lessened its stake in shares of McKesson Co. (NYSE:MCK – Get Rating) by 21.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 256 shares of the company’s stock after selling 69 shares during the period. Crewe Advisors LLC’s […]

Beck Bode LLC lessened its stake in Pfizer Inc. (NYSE:PFE – Get Rating) by 15.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,114 shares of the biopharmaceutical company’s stock after selling 1,142 shares during the period. Beck […]

Beck Bode LLC lessened its holdings in Visa Inc. (NYSE:V – Get Rating) by 63.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,009 shares of the credit-card processor’s stock after selling 3,414 shares during the quarter. Beck Bode LLC’s holdings in Visa were […]

PDD (NASDAQ:PDD – Get Rating) had its target price cut by Citigroup from $115.00 to $100.00 in a research report released on Tuesday morning, The Fly reports. Other equities analysts also recently issued research reports about the company. Morgan Stanley upgraded PDD from an equal weight rating to an overweight rating and upped their target […]

Boston Partners increased its stake in shares of NexTier Oilfield Solutions Inc. (NYSE:NEX – Get Rating) by 27.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,317,224 shares of the company’s stock after buying an additional 934,921 shares during the quarter. […]

Beck Bode LLC purchased a new stake in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) in the 4th quarter, Holdings Channel reports. The fund purchased 4,811 shares of the company’s stock, valued at approximately $651,000. Several other hedge funds and other institutional investors have also recently made changes to their positions in NVO. […]